1. Home
  2. QGEN

as of 12-11-2025 12:48pm EST

$45.31
$0.35
-0.77%
Stocks Health Care Biotechnology: Biological Products (No Diagnostic Substances) Nasdaq

Qiagen offers proprietary sample and assay technology to extract, purify, amplify, and interpret DNA, RNA, and proteins. The company's sales are split almost evenly between applications in life sciences and molecular diagnostics. Qiagen generates nearly 90% of its revenue from consumables with the balance coming from instrumentation and related services. The Americas account for the largest portion of the firm's revenue (52% of 2024 sales), followed by EMEA (33%), and the Asia-Pacific (15%).

Chart Type:
Time Range:
Founded: 1986 Country:
Netherlands
Netherlands
Employees: N/A City: N/A
Market Cap: 10.2B IPO Year: 1996
Target Price: $50.68 AVG Volume (30 days): 1.2M
Analyst Decision: Buy Number of Analysts: 7
Dividend Yield:
3.31%
Dividend Payout Frequency: Annual
EPS: 1.84 EPS Growth: 331.20
52 Week Low/High: $37.63 - $51.88 Next Earning Date: 11-04-2025
Revenue: $2,070,781,000 Revenue Growth: 5.32%
Revenue Growth (this year): 7.12% Revenue Growth (next year): 6.13%

AI-Powered QGEN Daily Prediction

Machine learning model trained on 25+ technical indicators

Updated 18 hours ago

AI Recommendation

hold
Model Accuracy: 76.35%
76.35%
Confidence

Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.

Share on Social Networks: